Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron

BioMetals

Volumn 30, Issue 2, 2017, Pages 285-293

  Tahmasebinia, Foozhan ^a   Emadi, Saeed ^a  

^a INSTITUTE FOR ADVANCED STUDIES IN BASIC SCIENCES IASBS   (Iran)

Author keywords

Clioquinol; Cu(II) ion; EDTA; Fe(III) ion; amyloid peptide

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CHELATING AGENT; CLIOQUINOL; CUPRIC ION; EDETIC ACID; FERRIC ION; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); CATION; COPPER; IRON; PEPTIDE FRAGMENT; PROTEIN AGGREGATE;

ARTICLE; ATOMIC FORCE MICROSCOPY; BLOOD BRAIN BARRIER; FLUORESCENCE SPECTROSCOPY; PROTEIN AGGREGATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; CHEMISTRY; DRUG EFFECTS; HUMAN; SOLUTION AND SOLUBILITY;

AMYLOID BETA-PEPTIDES; CATIONS; CHELATING AGENTS; CLIOQUINOL; COPPER; EDETIC ACID; HUMANS; IRON; MICROSCOPY, ATOMIC FORCE; PEPTIDE FRAGMENTS; PROTEIN AGGREGATES; SOLUTIONS;

EID: 85014632270     PISSN: 09660844     EISSN: 15728773     Source Type: Journal    
DOI: 10.1007/s10534-017-0005-2     Document Type: Article

References (19)

1. Cukalevski R, Yang X, Meisl G, Weininger U, Bernfur K, Frohm B, Knowles TP, Linse S (2015) The Aβ40 and Aβ42 peptides self-assemble into separate homomolecular fibrils in binary mixtures but cross-react during primary nucleation. Chem Sci 6:4215–4233
2. Faller P, Hureau C, Berthoumieu O (2013) Role of metal ions in the self-assembly of the Alzheimer’s amyloid Aβ peptide. Inorg Chem 52:12193–12206
3. Gu L, Tran J, Jiang L, Guo Z (2016) A new structural model of Alzheimer’s Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling. J Struct Biol 194:61–67
4. Horcas I, Fernández R, Gomez-Rodriguez JM, Colchero J, Gómez-Herrero J, Baro AM (2007) WSXM: a software for scanning probe microscopy and a tool for nanotechnology. Rev Sci Instrum 78:013705
5. Jamasbi E, Wade DJ, Separovic F, Mohammed AH (2016) Amyloid beta (aβ) peptide and factors that play important roles in Alzheimer’s disease. Curr Med Chem 23:884–892
6. Jiang D, Rauda I, Han S, Chen S, Zhou F (2012) Aggregation pathways of the amyloid β(1−42) peptide depend on its colloidal stability and ordered β-sheet stacking. Langmuir 28:12711–12721
7. Kong X, Zhao Z, Lei X, Zhang B, Dai D, Jiang L (2015) Interaction of metal ions with the his13-his14 sequence relevant to Alzheimer’s disease. J Phys Chem A 119:3528–3534
8. Lim MH, Mancino AM, Hindo SS, Kochi A (2009) Effects of clioquinol on metal-triggered amyloid-β aggregation revisited. Inorg Chem 48:9596–9598
9. Matlack KES, Tardiff DF, Narayan P, Hamamichi S, Caldwell KA, Caldwell GA, Lindquist S (2014) Clioquinol promotes the degradation of metal-dependent amyloid-β (aβ) oligomers to restore endocytosis and ameliorate aβ toxicity. Proc Nat Acad Sci USA 111:4013–4018
10. Orvig C, Rodríguez-Rodríguez C, Telpoukhovskaia M (2012) The art of building multifunctional metal-binding agents from basic molecular scaffolds for the potential application in neurodegenerative diseases. Coord Chem Rev 256:2308–2332
11. Prachayasittikul V, Prachayasittikul S, Ruchirawat S, Prachayasittikul V (2013) 8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications. Drug Des Devel Ther 7:1157–1178
12. Robert A, Liu Y, Nguyen M, Meunier B (2015) Regulation of copper and iron homeostasis by metal chelators: a possible chemotherapy for Alzheimer’s disease. Acc Chem Res 48:1332–1339
13. Sakono M, Zako T (2010) Amyloid oligomers: formation and toxicity of Aβ oligomers. FEBS J 277:1348–1358
14. Santos MA, Chand K, Chaves S (2016) Recent progress in multifunctional metal chelators as potential drugs for Alzheimer’s disease. Coord Chem Rev 327:287–303
15. Sastre M, Ritchie CW, Hajji N (2015) Metal ions in Alzheimer’s disease brain. JSM Alzheimer’s Dis Rel Dement 2:1014–1019
16. Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med 8:595–608
17. Tiiman A, Krishtal J, Palumaa P, Tõugu V (2015) In vitro fibrillization of Alzheimer’s amyloid-β peptide (1–42). AIP Adv 5:092401
18. Wallin C, Kulkarni YS, Abelein A, Jarvet J, Liao Q, Strodel B, Olsson L, Luo J, Abrahams JP, Sholts SB, Roos PM (2016) Characterization of Mn(II) ion binding to the amyloid-β peptide in Alzheimer’s disease. J Trace Elem Med Bio 38:183–193
19. Wineman-Fisher V, Bloch DN, Miller Y (2016) Challenges in studying the structures of metal-amyloid oligomers related to type 2 diabetes, Parkinson’s disease, and Alzheimer’s disease. Coord Chem Rev 327:20–26